Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis

Abstract

Objective

The aim of this study is to determine whether the functional interferon regulatory factor 5 (IRF5) polymorphism rs2004640 is associated with susceptibility to systemic lupus erythematosus (SLE) in multiple ethnic populations.

Methods

A meta-analysis was conducted on the T allele of the IRF5 rs2004640 polymorphism in all study participants as well as each ethnic population.

Results

Twenty research articles that included 28 comparative studies of 20,892 patients and 24,930 controls were included in the meta-analysis. The Asian population had a much lower prevalence of the T allele than any other study population at 28%, and the European population had the highest prevalence of the T allele at 52%. Meta-analysis showed an association between the IRF5 rs2004640 polymorphism and SLE in all participants (odds ratio = 1.472, 95% confidence interval = 1.370–1.582, p < 0.001). Analysis after stratification by ethnicity indicated that the IRF5 rs2004640 T allele is significantly associated with SLE in Europeans, Asians, Latin Americans and Arabs.

Conclusions

This meta-analysis confirms that the IRF5 rs2004640 polymorphism is associated with SLE susceptibility in different ethnic groups, and that its prevalence is ethnicity dependent.

Keywords

meta-analysis polymorphism systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Banchereau

Pascual

. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383–392.

Taniguchi

Ogasawara

Takaoka

Tanaka

. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623–655.

Devaraju

Mehra

Gulati

et al.

The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India. Indian J Med Res 2018; 147: 560–566.

Ruhizadeh

Imeni

Angaji

et al.

Association of IRF5 gene single nucleotide polymorphism with systemic lupus erythematosus susceptibility in Iranian population. Gene Rep 2018; 12: 175–178.

Zervou

Dorschner

Ghodke-Puranik

Boumpas

Niewold

Goulielmos

. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island. Gene 2017; 610: 9–14.

Hammad

Mossad

Nasef

Eid

. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus. Lupus 2017; 26: 871–880.

Tang

Wan

Wang

Pan

Wang

Chen

. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population. Inflamm Res 2015; 64: 817–824.

Wen

Fang

Liu

Zheng

Lin

. Associations of genetic polymorphisms of TLR5, TLR9 and transduction molecules in MyD88 signaling pathway with systemic lupus erythematosus in Zhuang and Han ethnics of Guangxi province, China. Int J Clin Exp Med 2015; 8: 7872–7880.

Dang

Shan

et al.

Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Tissue Antigens 2014; 83: 401–408.

10.

Nordang

Viken

Amundsen

et al.

Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts. Rheumatology (Oxford) 2012; 51: 619–626.

11.

Qin

Zhou

Hou

Yang

Zhang

. Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton) 2010; 15: 710–713.

12.

Vuong

Gunnarsson

Lundberg

et al.

Genetic risk factors in lupus nephritis and IgA nephropathy—no support of an overlap. PLoS One 2010; 5: e10559.

13.

Löfgren

Yin

Delgado-Vega

et al.

Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J Rheumatol 2010; 37: 574–578.

14.

Song

Chen

Yuan

Yin

. Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population [article in Chinese]. Zhonghua Yi Xue Za Zhi 2009; 89: 3038–3042.

15.

Kawasaki

Kyogoku

Ohashi

et al.

Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: Support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 2008; 58: 826–834.

16.

Kelly

Kelley

Kaufman

et al.

Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008; 9: 187–194.

17.

Siu

Yang

Lau

et al.

Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J Rheumatol 2008; 35: 360–362.

18.

Reddy

Velázquez-Cruz

Baca

et al.

Genetic association of IRF5 with SLE in Mexicans: Higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 2007; 121: 721–727.

19.

Demirci

Manzi

Ramsey-Goldman

et al.

Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet 2007; 71(Pt 3): 308–311.

20.

Shin

Kim

Choi

Lee

Bae

. Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population. J Rheumatol 2008; 35: 2148–2151.

21.

Graham

Kozyrev

Baechler

et al.

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555.

22.

Sigurdsson

Nordmark

Göring

et al.

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528–537.

23.

Moher

Liberati

Tetzlaff

Altman

PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6: e1000097.

24.

Higgins

Thompson

. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.

25.

Egger

Smith

Phillips

. Meta-analysis: Principles and procedures. BMJ 1997; 315: 1533–1537.

26.

DerSimonian

Laird

. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

27.

Egger

Davey Smith

Schneider

Minder

. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.

28.

Duval

Tweedie

. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.

29.

Lee

Song

. Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: A meta-analysis. Rheumatol Int 2009; 29: 1137–1142.

30.

Honda

Yanai

Takaoka

Taniguchi

. Regulation of the type I IFN induction: A current view. Int Immunol 2005; 17: 1367–1378.

31.

Takaoka

Yanai

Kondo

et al.

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243–249.

32.

Tackey

Lipsky

Illei

. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 2004; 13: 339–343.

33.

Kozyrev

Alarcón-Riquelme

. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007; 40: 591–601.

34.

Mancl

Sangster-Guity

et al.

Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 2005; 280: 21078–21090.

35.

Graham

Kyogoku

Sigurdsson

et al.

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007; 104: 6758–6763.